Rapid Micro Biosystems (RPID) Long-Term Investments (2020 - 2023)
Rapid Micro Biosystems (RPID) reported Long-Term Investments of $2.9 million for Q4 2023, down 90.23% on a YoY basis from $29.8 million in Q4 2022, and down 80.09% sequentially from $14.6 million in Q3 2023.
Rapid Micro Biosystems (RPID) Long-Term Investments (2020 - 2023) Analysis & Trends
Rapid Micro Biosystems (RPID) has 4 years of Long-Term Investments data on file, last reported at $2.9 million in Q4 2023.
- For the quarter ending Q4 2023, Long-Term Investments fell 90.23% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2023 stood at $2.9 million (down 90.23% YoY), and the FY2023 full-year result was $2.9 million, down 90.23% from the prior year.
- Long-Term Investments slipped to $2.9 million in Q4 2023, from $14.6 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $35.2 million in Q3 2022 to a low of $695000.0 in Q4 2020.
- A 4-year average of $14.2 million and a median of $12.3 million in 2021 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments surged 2512.31% in 2022 and slumped 90.23% in 2023, its largest moves.
- Tracing RPID's Long-Term Investments over 4 years: stood at $695000.0 in 2020, then soared by 1333.96% to $10.0 million in 2021, then jumped by 198.92% to $29.8 million in 2022, then tumbled by 90.23% to $2.9 million in 2023.
- Business Quant data shows RPID's Long-Term Investments at $2.9 million in Q4 2023, $14.6 million in Q3 2023, and $7.2 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 14.62 Mn |
| Jun 30, 2023 | 7.25 Mn |
| Mar 31, 2023 | 22.46 Mn |
| Dec 31, 2022 | 29.79 Mn |
| Sep 30, 2022 | 35.21 Mn |
| Jun 30, 2022 | 22.82 Mn |
| Mar 31, 2022 | 21.94 Mn |
| Dec 31, 2021 | 9.97 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Dec 31, 2020 | 695,000.00 |